Medical News You May Have Missed (Week of Jan. 14)
The FDA requires reductions in recommended doses of zolpidem; update on the flu; new BP goals for patients with diabetes; selective use of D-Dimer for suspected DVT; new food safety standards. . . here: 5 quick summaries of medical news headlines with links out to original sources. (Source: Consultant Live)
Source: Consultant Live - January 15, 2013 Category: Primary Care Source Type: news
FDA Cuts Ambien Dosages to Curb Drowsy Driving
Inside the life of a pro dancer: Hardships and sacrifices; Plus, food trends: What's in store for 2013 (Source: U.S. News - Health)
Source: U.S. News - Health - January 11, 2013 Category: Consumer Health News Source Type: news
Video: Wakeup call? FDA revises dosing guidelines for Ambien
The FDA has new guidelines for the sleeping pill, Ambien -- and all sleep aids with zolpidem. Dr. Carol Ash, director of sleep medicine at Meridian Health, talks to Charlie Rose and Norah O'Donnell about the recommendations. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - January 11, 2013 Category: Consumer Health News Source Type: news
Transcept Pharmaceuticals Comments on New FDA Dosage Reduction Requirements for Zolpidem Based Prescription Sleep Aids Administered at Bedtime
FDA-mandated zolpidem dosage reduction for bedtime products such
as Ambien (5 mg and 10 mg tablets) and Ambien CR (6.25 mg and 12.5
mg tablets) does not affect Intermezzo® (zolpidem tartrate
1.75 mg and 3.5 mg sublingual tablets) C-IV... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 11, 2013 Category: Pharmaceuticals Source Type: news
FDA requires lower dosage for insomnia drugs
The Food and Drug Administration announced Thursday it is requiring manufacturers of insomnia products, such as Ambien, Edluar and Zolpimist, to lower their current recommended doses. (Source: WDSU.com - Health)
Source: WDSU.com - Health - January 11, 2013 Category: Consumer Health News Source Type: news
FDA: Lower Ambien's Dose to Prevent Drowsy Driving
Title: FDA: Lower Ambien's Dose to Prevent Drowsy DrivingCategory: Health NewsCreated: 1/10/2013 2:37:00 PMLast Editorial Review: 1/11/2013 12:00:00 AM (Source: MedicineNet Sleep General)
Source: MedicineNet Sleep General - January 11, 2013 Category: Sleep Medicine Source Type: news
FDA Drug Safety Communication recommends lower doses of zolpidem
Source: FDA
Area: News
The FDA is recommending that the bedtime dose of zolpidem be lowered because new data show that blood levels in some patients may be high enough the morning after use to impair activities that require alertness, including driving.
The data show that the risk for next-morning impairment is highest for patients taking the extended-release forms of these drugs (not available in UK) and women appear to be more susceptible to this risk because they eliminate zolpidem from their bodies more slowly than men.
As use of lower doses of zolpidem will result in lower blood levels in the m...
Source: NeLM - News - January 11, 2013 Category: Drugs & Pharmacology Source Type: news
FDA recommends lower dose of zolpidem for patient safety
In a drug safety communication, FDA has recommended that the bedtime dose of zolpidem, for the
treatment of insomnia, be lowered because new data show that blood levels in some patients may be high enough the
morning after use to impair activities that require alertness, including driving. (Source: Modern Medicine)
Source: Modern Medicine - January 11, 2013 Category: Journals (General) Source Type: news
FDA Drug Safety Communication: Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist)
(Healthcare Sales & Marketing Network)--The U.S. Food and Drug Administration (FDA) is notifying the public of new information about zolpidem, a widely prescribed insomnia drug. FDA recommends that the bedtime dose be lowered because new data show that blo... Biopharmaceuticals, FDASanofi, Ambien , zolpidem (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 11, 2013 Category: Pharmaceuticals Source Type: news
FDA advises cut in Ambien dose
WASHINGTON, Jan. 10 (UPI) -- The U.S. Food and Drug Administration said the dose of Ambien, a widely prescribed sleeping pill, might be high enough the day after use to impair driving. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 11, 2013 Category: Consumer Health News Source Type: news
Video: FDA calling for lower doses of Ambien
The FDA released new guidelines for the popular sleeping pill Ambien and drugs with the same active ingredient. Scott Pelley speaks with Dr. Jon LaPook about why the FDA acted and why recommendations are different for men and women. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - January 11, 2013 Category: Consumer Health News Source Type: news
FDA Reduces Dosage Recommendations Of Sleeping Pills Containing Zolpidem
Manufacturers of sleeping pills with an active ingredient called zolpidem are being forced by the U.S. Food and Drug Administration (FDA) to reduce the current recommended dose of the medications. This measure comes following new evidence showing that the zolpidem blood levels of some people the day after taking the medications can severely impair their alertness and ability to perform tasks, such as driving or handling machinery. Zolpidem remains in the blood the morning after taking it... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 10, 2013 Category: Consumer Health News Tags: Sleep / Sleep Disorders / Insomnia Source Type: news
Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses Including Ambien, Ambien CR, Edluar, and Zolpimist
AUDIENCE: Family Practice, Health Professional, Patient
ISSUE: FDA is notifying the public of new information about
zolpidem, a widely prescribed insomnia drug. FDA recommends that
the bedtime dose be lowered because new data show that blood... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 10, 2013 Category: Pharmaceuticals Source Type: news
FDA: Lower Ambien's Dose to Prevent Drowsy Driving
Blood levels from nighttime dose remain too high the next morning, agency says
Source: HealthDay
Related MedlinePlus Pages: Drug Safety, Insomnia (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - January 10, 2013 Category: Consumer Health News Source Type: news
FDA Requires Lower Sleep-Drug Doses
The FDA is requiring the makers of certain sleep drugs, including Ambien, to reduce doses of the medicines because they have been shown to impair activities like driving the morning after the drugs have been taken. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 10, 2013 Category: Pharmaceuticals Tags: FREE Source Type: news
